Onyx Rejects Amgen Offer, Explores Possible Sale

01.07.2013 - Cancer drugmaker Onyx Pharmaceuticals said on Sunday it rejected a roughly $10 billion takeover offer from larger biotechnology company Amgen as too low but still is considering...